SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant buzz due to its ultra-low circulating supply of 19 million coins and a market cap that supporters view as severely undervalued. The community is actively discussing the potential for a massive price surge driven by scarcity and upcoming integrations in the DePin and DeFi sectors, with many investors advocating for a buy-and-hold strategy to trigger a supply shock.

MEME COIN: $ROAR is the OG token. Est. Sept '22. Inspired by The Roaring Kitty Who Inspired other to fight against wall street through Game Stop.  We Are  100% community-owned.  LP burnt.  Contract Renounced  Ready to Moon like $GME &amp; $AMC?

Roaring Kitty

The Roaring Kitty token ($ROAR) is currently trending as a community-driven play that aims to capture the momentum of the GameStop (GME) narrative and retail investor sentiment. Community members are actively highlighting the project's decentralized structure, ongoing liquidity pool developments, and potential exchange listings as key catalysts for growth.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing a sharp sell-off driven by a high-profile analyst downgrade and investor rotation as participants pivot toward the potential SpaceX IPO. The community remains deeply divided, with bears pointing to stretched valuations and delivery challenges while bulls dismiss the volatility as a coordinated short attack aimed at accumulating shares ahead of future company milestones.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing a significant rebound in investor interest as the market digests its recent AAA-rated ABS transaction and the successful onboarding of new institutional partners. While community members remain cautious of broader macro volatility, many are actively highlighting the stock's oversold technical setup and emphasizing the company's resilient AI-driven business model as a key catalyst for potential recovery.

Provides investment banking, securities and asset management services

Goldman Sachs Group, Inc.

Goldman Sachs is trending due to institutional focus on their resilience amid broader market volatility and their strategic positioning in private credit and high-growth sectors. Community discourse is currently split between analysts highlighting their institutional strength versus active traders closely monitoring technical support levels and broader sector concerns.

Invesco Exchange-Traded Fund Trust II - Invesco KBW Bank ETF

Invesco KBW Bank ETF

The Invesco KBW Bank ETF is currently capturing investor interest amid ongoing volatility in the banking sector and diverging perspectives on interest rate policy. Market participants are closely watching the ETF for signals of stability as the sector grapples with shifting credit concerns and broader economic uncertainty.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos Defense is trending as investors weigh the impact of a massive $1.17 billion public offering against the backdrop of heightened geopolitical tensions and expanding defense spending. While some in the community are concerned about short-term dilution, many bullish market participants view the capital raise as a strategic move to aggressively scale production for a significant backlog of drone and hypersonic missile orders.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing extreme volatility and intense community frustration as participants debate its long-term viability amid ongoing price declines and regulatory uncertainty. While some users are aggressively averaging down and holding onto their positions in hopes of a future turnaround driven by institutional adoption, others are actively exiting, labeling the project a disappointment compared to broader market performance.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant market interest following a higher-than-expected final Medicare Advantage rate hike, which investors view as a critical relief catalyst for the managed care sector. While some market participants are celebrating this as a potential floor for the stock, community sentiment remains split, with many analysts and traders debating whether this news is enough to overcome ongoing regulatory headwinds and persistent sector volatility.

Inflection Point Acquisition Corp. IV is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Andrew Stephen Gundlach and Michel Combes on June 24, 2024 and is headquartered in New York, NY.

Merlin Inc.

Investors are closely monitoring Merlin Inc. as the company expands its leadership team and advances high-stakes autonomous flight contracts with the U.S. Department of Defense. Community sentiment remains split, with bulls highlighting the potential of its aircraft-agnostic software while bears express skepticism toward the company's long-term certification roadmap and valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wedbush Forecasts Strong Price Appreciation for Black Diamond Therapeutics (NASDAQ:BDTX) Stock

Wedbush upped their price objective on shares of Black Diamond Therapeutics from $13.00 to $14.00 and gave the company an "outperform" rating in a research note on Tuesday...

Black Diamond Therapeutics (NASDAQ:BDTX) Releases Earnings Results

Black Diamond Therapeutics (NASDAQ:BDTX - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the...

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Day One's stock surges 66% after Servier agrees to acquire it for $21.50 per share in a $2.5B deal, adding brain tumor drug Ojemda and oncology pipeline assets.

Black Diamond Therapeutics Teases Next-Quarter PFS Data for Silevertinib at TD Cowen Conference

Black Diamond Therapeutics (NASDAQ:BDTX) used a presentation at the 46th annual TD Cowen Healthcare Conference to highlight progress for its lead program, silevertinib, a fourth-generation epidermal...

Black Diamond Therapeutics (BDTX) Expected to Announce Quarterly Earnings on Thursday

Black Diamond Therapeutics (NASDAQ:BDTX) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 5. (View Earnings Report at...

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Given Average Rating of "Moderate Buy" by Analysts

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eight analysts that are covering the firm, MarketBeat reports. One...

Black Diamond Therapeutics (NASDAQ:BDTX) Stock Price Up 0.5% - Here's Why

Black Diamond Therapeutics (NASDAQ:BDTX) Trading 0.5% Higher - Here's Why...

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034)  DelveInsight

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast...

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the...

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

Here is how Black Diamond (BDTX) and Bionano Genomics, Inc. (BNGO) have performed compared to their sector so far this year.

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases. It is currently focused on advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

BDTX
Black Diamond Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BDTX News

BDTXBlack Diamond Therapeutics Inc